Neuropathic pain |
Neuroma |
Axotomy (complete sciatic nerve transection) |
Causalgia; neuropathies; chronic widespread pain (CWP); complex regional pain syndrome (CRPS); temporomandibular disorder (TMD); peripheral nerve injured by trauma |
Chronic constriction injury (CCI); partial sciatic nerve ligation (PSL); spinal nerve ligation (SNL); cuffing-induced sciatic nerve injury (PNI); spared nerve injury (SNI) |
Trigeminal neuralgia |
Compression of trigeminal ganglion; CCI to infra-orbital nerve |
Low back pain |
Nucleus pulposus (NP) applied to the lumbar dorsal root ganglia (DRG) and/or adjacent nerve roots (NP) model; chronic compression of the DRG model (CCD); L5 DRG is inflamed by zymosan in incomplete Freund’s adjuvant |
Postoperative pain |
Incision model |
Diabetes-induced neuropathy |
Streptozotocin (STZ) -induced neuropathy model |
Post-herpetic neuralgia |
Varicella zoster virus-induced neuropathy |
Inflammatory pain |
Peripheral nerve inflammation |
Cutaneous and subcutaneous models: complete Freund’s adjuvant (CFA); formalin model; carrageenan model |
Inflammatory bowel disease (IBD) |
Dextran sodium sulfate (DSS); 2,4,6-trinitrobenzene sulfonic acid (TNBS) |
Arthritis |
Joint inflammation models: CFA; carrageenan; Collagen-induced arthritis (CIA); Collagen-antibody-induced arthritis |
Fibromyalgia symptoms (FMS) |
Intraperitoneal injection with IgG fibromyalgia patients |
Cancer pain |
Tumor mestastases to the skeleton |
Bone cancer pain models: femur, calcaneus, tibial with inoculation of cancerous cells into respective bones |
Melanoma skin cancer |
Injection of melanoma cells in plantar region of hind paw |
Drug-induced pain |
Cancer patients after drug treatment |
Anti-cancer agents (vincristine, cisplatin, oxaliplatin, paclitaxel) models |
Anti-HIV drugs-induced neuropathy |
Anti-HIV agents (2,3-dideoxycytidine, didanosine) |